Degroof Petercam Asset Management’s Legend Biotech LEGN Stock Holding History

Degroof Petercam Asset Management’s Portfolio LEGN Stock Details LEGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$146K	Buy	+2,600	New	+$157K	﹤0.01%	610

Other funds holding LEGN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Degroof Petercam Asset Management's LEGN Position: Q1 2024 in Review

Degroof Petercam Asset Management opened a new position in Legend Biotech (LEGN) in Q1 2024: 2,600 shares worth $146K. The stake represents ﹤0.01% of the portfolio and ranks #610 among its holdings.

192 funds tracked by Wall St. Rank hold LEGN as of Q1 2024.

Degroof Petercam Asset Management held 2,600 shares of Legend Biotech worth $146K as of Q1 2024.
Legend Biotech was a new Degroof Petercam Asset Management position in Q1 2024.
Legend Biotech made up ﹤0.01% of Degroof Petercam Asset Management's portfolio in Q1 2024, its #610 holding.
192 funds tracked by Wall St. Rank held Legend Biotech as of Q1 2024.

Based on Degroof Petercam Asset Management's 13F filing for Q1 2024, filed 13 May 2024.